{"id":19276,"date":"2021-10-01T14:11:01","date_gmt":"2021-10-01T12:11:01","guid":{"rendered":"https:\/\/p-xq7l1i.project.space\/?page_id=19276"},"modified":"2023-05-19T10:25:16","modified_gmt":"2023-05-19T08:25:16","slug":"healthcare-med-tech","status":"publish","type":"page","link":"https:\/\/aquin.com\/en\/industries\/healthcare-med-tech\/","title":{"rendered":"Healthcare & Med-Tech"},"content":{"rendered":"

<\/div><\/div>

back to industry overview<\/a><\/p>\n<\/div>

HEALTHCARE & MED-TECH<\/h1><\/div>

\u00bbThe MedTech industry will change significantly over the coming years. Demographics and advanced medical technologies are placing additional demands on medical service providers. Business models need to be adapted to manage the shift from fee-for-service to value-based healthcare.
\nThe increasing economic importance of health is pressuring MedTech companies to help their customers to achieve better outcomes at a much lower cost. Many German medium-sized companies have achieved great success through their technological leadership. If they want to remain sucessful in this market, they will have to invest all their energy in the digitalization of their business models, in mastering the increased regulatory requirements and in their own international growth.
\nM&A can play a key role here.\u00ab<\/p>\n<\/div>

Prof. Dr. Hermann Requardt, Senior Advisor for the MedTech Industry at Aquin, <\/strong>
\nFormer CEO of Siemens Healthcare<\/p>\n<\/div><\/div><\/div><\/div><\/div>

SENIOR ADVISOR<\/h1><\/div>